Article
Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
Cancer letters - 1 Feb 2017
Hess Julia, Unger Kristian, Orth Michael, Schötz Ulrike, Schüttrumpf Lars, Zangen Verena, Gimenez-Aznar Igor, Michna Agata, Schneider Ludmila, Stamp Ramona, Selmansberger Martin, Braselmann Herbert, Hieber Ludwig, Drexler Guido A, Kuger Sebastian, Klein Diana, Jendrossek Verena, Friedl Anna A, Belka Claus, Zitzelsberger Horst, Lauber Kirsten
Abstract excerpt
Radio (chemo) therapy is a crucial treatment modality for head and neck squamous cell carcinoma (HNSCC), but relapse is frequent, and the underlying mechanisms remain largely elusive. Therefore, novel biomarkers are urgently needed. Previously, we identified gains on 16q23-24 to be associated with amplification of the Fanconi anemia A (FancA) gene and to correlate with reduced progression-free survival after...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
